glp 1 shortage guidance FDA restricts non-approved compounded GLP-1 weight loss products GLP-1 Market Size, Share |

Diabetes Care 44, 14621471

Pre-treatment with melatonin or glutathione attenuated apoptotic and inflammatory responses and restored AMH immunoreactivity to near-control levels

Our analyses uncover a bidirectional relationship between kidney function and TMAO that can potentially be modified by reno-protective anti-diabetic drugs and suggest a clinically actionable intervention for decreasing TMAO-associated excess cardiovascular risk

Yousuf, E

doi: 10.1016/j.pharmthera.2022.108277 103 LinZSurSLiuPLiYJiangDHouXet al

The arrival of tablets could encourage entirely new groups of patients to consider GLP-1 treatment for the first time